4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-18-064322
10% owner bought 40,198 shares at an average $24.93 ($1,002,194)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals (Europe) Ltd 10% owner | 2018-12-26 | Purchase | +12,737 | $24.89 | $317,077 | 5,353,479 | D |
| Vertex Pharmaceuticals (Europe) Ltd 10% owner | 2018-12-27 | Purchase | +27,461 | $24.95 | $685,116 | 5,380,940 | D |
| Open-market purchases · 40,198 sh · avg $24.93 · $1,002,194 | |||||||
Loading xslF345X03/doc4.xml…